The PDE9A inhibitor Bay 73-6691 maintains the balance of CHIP-mediated cGMP/cAMP signalling crosstalk, ameliorating Purkinje cell mitophagy disturbance-induced ARCA neuropathological alterations. The gene discussed is PDE9A; the disease is autosomal recessive cerebellar ataxia.